158 related articles for article (PubMed ID: 10557053)
1. Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia.
Lensch MW; Rathbun RK; Olson SB; Jones GR; Bagby GC
Leukemia; 1999 Nov; 13(11):1784-9. PubMed ID: 10557053
[TBL] [Abstract][Full Text] [Related]
2. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
[TBL] [Abstract][Full Text] [Related]
3. Fanconi anemia.
Soulier J
Hematology Am Soc Hematol Educ Program; 2011; 2011():492-7. PubMed ID: 22160080
[TBL] [Abstract][Full Text] [Related]
4. Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia.
Pulliam-Leath AC; Ciccone SL; Nalepa G; Li X; Si Y; Miravalle L; Smith D; Yuan J; Li J; Anur P; Orazi A; Vance GH; Yang FC; Hanenberg H; Bagby GC; Clapp DW
Blood; 2010 Oct; 116(16):2915-20. PubMed ID: 20606166
[TBL] [Abstract][Full Text] [Related]
5. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
Venkatraj VS; Gaidano G; Auerbach AD
Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells.
Li J; Sejas DP; Zhang X; Qiu Y; Nattamai KJ; Rani R; Rathbun KR; Geiger H; Williams DA; Bagby GC; Pang Q
J Clin Invest; 2007 Nov; 117(11):3283-95. PubMed ID: 17960249
[TBL] [Abstract][Full Text] [Related]
7. Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms.
Chao MM; Thomay K; Goehring G; Wlodarski M; Pastor V; Schlegelberger B; Schindler D; Kratz CP; Niemeyer C
Klin Padiatr; 2017 Nov; 229(6):329-334. PubMed ID: 29132164
[TBL] [Abstract][Full Text] [Related]
8. Fanconi anemia and the development of leukemia.
Alter BP
Best Pract Res Clin Haematol; 2014; 27(3-4):214-21. PubMed ID: 25455269
[TBL] [Abstract][Full Text] [Related]
9. Two different karyotypes with 1q abnormalities in a patient with Fanconi anemia.
Oliveira NI; Ribeiro EM; Raimondi SC; Bittencourt MA; Pasquini R; Cavalli IJ
Leuk Res; 2002 Nov; 26(11):1047-9. PubMed ID: 12363475
[TBL] [Abstract][Full Text] [Related]
10. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.
Quentin S; Cuccuini W; Ceccaldi R; Nibourel O; Pondarre C; Pagès MP; Vasquez N; Dubois d'Enghien C; Larghero J; Peffault de Latour R; Rocha V; Dalle JH; Schneider P; Michallet M; Michel G; Baruchel A; Sigaux F; Gluckman E; Leblanc T; Stoppa-Lyonnet D; Preudhomme C; Socié G; Soulier J
Blood; 2011 Apr; 117(15):e161-70. PubMed ID: 21325596
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics.
Cioc AM; Wagner JE; MacMillan ML; DeFor T; Hirsch B
Am J Clin Pathol; 2010 Jan; 133(1):92-100. PubMed ID: 20023263
[TBL] [Abstract][Full Text] [Related]
12. Fanconi anemia: myelodysplasia as a predictor of outcome.
Alter BP; Caruso JP; Drachtman RA; Uchida T; Velagaleti GV; Elghetany MT
Cancer Genet Cytogenet; 2000 Mar; 117(2):125-31. PubMed ID: 10704682
[TBL] [Abstract][Full Text] [Related]
13. Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis.
Freie B; Li X; Ciccone SL; Nawa K; Cooper S; Vogelweid C; Schantz L; Haneline LS; Orazi A; Broxmeyer HE; Lee SH; Clapp DW
Blood; 2003 Dec; 102(12):4146-52. PubMed ID: 12855557
[TBL] [Abstract][Full Text] [Related]
14. Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor.
Tönnies H; Huber S; Kuhl JS; Gerlach A; Ebell W; Neitzel H
Blood; 2003 May; 101(10):3872-4. PubMed ID: 12511406
[TBL] [Abstract][Full Text] [Related]
15. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
16. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
Babushok DV; Bessler M
Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
[TBL] [Abstract][Full Text] [Related]
17. RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia.
Marion W; Koppe T; Chen CC; Wang D; Frenis K; Fierstein S; Sensharma P; Aumais O; Peters M; Ruiz-Torres S; Chihanga T; Boettcher S; Shimamura A; Bauer DE; Schlaeger T; Wells SI; Ebert BL; Starczynowski D; da Rocha EL; Rowe RG
Leukemia; 2023 Aug; 37(8):1698-1708. PubMed ID: 37391485
[TBL] [Abstract][Full Text] [Related]
18. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
Bernasconi P
Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
[TBL] [Abstract][Full Text] [Related]
20. Fanconi anemia type C-deficient hematopoietic cells are resistant to TRAIL (TNF-related apoptosis-inducing ligand)-induced cleavage of pro-caspase-8.
Platzbecker U; Kurre P; Guardiola P; Ward JL; Radich JP; Kiem HP; Deeg HJ
Exp Hematol; 2004 Sep; 32(9):815-21. PubMed ID: 15345282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]